Advance Care Planning and Care Coordination for People With Parkinson's Disease (PD_Pal)
Parkinson Disease, Parkinsonism
About this trial
This is an interventional supportive care trial for Parkinson Disease focused on measuring Advance Care Planning
Eligibility Criteria
Inclusion criteria for people with Parkinson's disease: Capable to participate , meaning that the subject is able to: understand information about the decision remember that information use that information to make a decision communicate their decision by talking, using sign language or any other means Able to provide informed consent; Meeting the MDS clinical diagnostic criteria for PD, including Parkinsonisms; Hoehn & Yahr ≥ 3; Progressive deterioration in physical and/or cognitive function despite optimal therapy, according to the primary physician; and Availability of a family caregiver or informal caregiver. Exclusion Criteria: Inability to communicate independently, with or without supportive communication tools; - Unable or unwilling to commit to study procedures; Presence of additional chronic medical illnesses which may require palliative services (e.g. metastatic cancer); Already receiving palliative care or hospice services; Already participating in a clinical study for palliative care. Inclusion criteria for family caregivers (FCs): Identified by the patient as the person closest to them; Willing to provide written informed consent; Willing and able to complete questionnaires; Aging ≥ 18 years. FC can only participate when the patient participates.
Sites / Locations
- Paracelsus Medical University
- Estonian Movement Disorders Society
- Philipps University Marburg Medical Center
- University of Ioannina
- University of Padova
- Skane University Hospital
- University College, London
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
PD_Pal intervention
Control group
Participants with Parkinson's disease receive usual care from their established neurology and/or home care team + the PD_Pal intervention.
Participants with Parkinson's disease receive usual care from their established neurology and/or home care team.